Smart software aims to make heart ablation more precise

NCT ID NCT07275151

Recruiting now Knowledge-focused Sponsor: CathVision ApS Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 4 times

Summary

This study tests a new software module that analyzes heart signals during a procedure called pulsed field ablation, used to treat atrial fibrillation. The goal is to see if the software can accurately tell doctors when the targeted heart veins are fully isolated. One hundred adults having their first ablation will be enrolled, and the software's results will be compared to the doctor's standard assessment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a more reliable way to confirm that heart tissue has been effectively treated during ablation, potentially improving outcomes for atrial fibrillation patients.
What could go wrong: This is an early, observational study focused on testing software, not a new treatment. It may not lead to any change in clinical practice or patient outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrial fibrillation paroxysmal atrial fibrillation persistent atrial fibrillation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATRIAL FIBRILLATION

Contacts and locations

Locations

The Valley Hospital
RECRUITING

Paramus, New Jersey, 07652, United States
Trinity Health Ann Arbor Hospital
NOT_YET_RECRUITING

Ypsilanti, Michigan, 48197, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.